Realistic Throat Model and Nasal Cavity Model
The standard Ph.Eur./USP Induction Port is known to poorly represent Aerosol transport through the upper respiratory tract. Using a more realistic nasal cavity model and throat models enables a more representative assessment of drug delivery to the target site.
Related News & Resources
New IPAC-RS paper offers insight and guidance for testing aqueous nasal inhalation products
02 November 2023; Nottingham, UK: A new paper from the International Pharmaceutical Aerosol Consortium on Regulation and Science (IPAC-RS) provides valuable insight on laboratory…
Find Out MoreIntroducing Inhalytix®: a new solution for analysing and managing inhaler test data from Copley
18 March 2021; Nottingham, UK: Inhalytix® is a completely new software solution from Copley, the global leader in inhaler testing equipment, that brings a…
Find Out MoreCopley introduces a comprehensive range for nasal product testing
11 March 2021, Nottingham, UK: Copley Scientific, the global leader in OINDP testing equipment, has introduced a series of new accessories that work with…
Find Out MoreCopley announces a major upgrade of the world’s ‘go to’ inhaler testing portfolio
01 March 2021, Nottingham, UK: Copley Scientific, the global leaders in inhaler testing equipment, is marking the company’s 75th anniversary with a significant upgrade…
Find Out MoreNasal Product Testing Brochure 2023 (2 mb)
Find Out MoreInhalation Article: April 2024
Improving the Utility of In Vitro Test Methods for Intranasal Drug Delivery In this article, Dr Clair Brooks, Applications Specialist, and Matthew Fenn, Head…
Find Out MorePoster: RDD 2023 (Henriques et al.)
Benchmarking of Particle Engineering Strategies for Nasal Powder Delivery: Characterization of Nasal Deposition using the Alberta Idealized Nasal Inlet Patricia Henriques1,2, Cláudia Costa1 ,…
Find Out MorePMPS Q&A (Samedan): April 2023
Nasal Drug Product Development Matthew Fenn, Head of Business Development, sat down with PMPS Magazine to discuss the topic of nasal drug testing and…
Find Out MoreRDD 2022 Poster: Chen et al.
In Vitro Regional Deposition of Nasal Sprays in an Idealized Nasal Inlet: Comparison with In Vivo Gamma Scintigraphy John Z. Chen, Warren H. Finlay…
Find Out MoreONdrugDelivery Article: November 2021
Improving In Vitro Test Methods for Nasal Drug Products In this article, we look at how in vitro testing is being refined for greater repeatability…
Find Out MoreManufacturing Chemist Feature: July 2021
Refining Test Methods for a New Generation of Nasal Drug Products The nasal drug product market is currently the focus of considerable research activity….
Find Out MoreMicrobioz India: February 2021
A short Q&A with our CEO, Mark Copley, on inhaled product testing
Find Out MoreInhalation Article: April 2019
The regulatory landscape for OINDPs – the biggest shake-up in a generation?
Find Out MoreDrug Development & Delivery Article: April 2018
Optimizing the Application of In Vitro Test Methods for the Demonstration of Bioequivalence in Orally Inhaled Products
Find Out MorePMPS Article (Samedan): February 2018
Demonstrating Bioequivalence of Orally Inhaled Products Safe and cost-effective treatments for respiratory diseases are facing a growing demand. The demonstration of bioequivalence within locally…
Find Out MoreWhite Paper: February 2018
Optimising the application of in vitro test methods for the demonstration of BE in OIPs
Find Out MoreAmerican Pharmaceutical Review Article: Nov/Dec 2017
Characterizing the Performance of Metered Dose Inhalers with Add-On Devices: New Methods For Clinically Relevant Testing
Find Out MoreRelated Services
Training
We offer a range of training courses, presentations and seminars covering a wide range of topics.
Find Out MoreServicing
A comprehensive range of both in-house and on-site product servicing options are available
Find Out MoreSupport
Our team of experienced technicians and engineers are on hand to help and advise
Find Out MoreHave a question? Our friendly and experienced team are here to help.